Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)

Pantelis Sarafidis; Charles J. Ferro; Enrique Morales; Alberto Ortiz; Jolanta Malyszko; Radovan Hojs; Khaled Khazim; Robert Ekart; Jose Valdivielso; Denis Fouque; Gérard M. London; Ziad Massy; Petro Ruggenenti; Esteban Porrini; Andrzej Wiecek; Carmine Zoccali; Francesca Mallamaci; Mads Hornum

doi:10.1093/ndt/gfz047

Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)

Pantelis Sarafidis, Charles J. Ferro, Enrique Morales, Alberto Ortiz, Jolanta Malyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, Jose Valdivielso, Denis Fouque, Gérard M. London, Ziad Massy, Petro Ruggenenti, Esteban Porrini, Andrzej Wiecek, Carmine Zoccali, Francesca Mallamaci, Mads Hornum

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Comment/debate

Abstract

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA, Nephrology Dialysis Transplantation, Volume 34, Issue 2, 1 February 2019, Pages 208–230, https://doi.org/10.1093/ndt/gfy407 In the above article the first name of author Andrzej Wiecek was misspelled. The error has been corrected online.

Original language	English
Pages (from-to)	1452
Number of pages	1
Journal	Nephrology Dialysis Transplantation
Volume	35
Issue number	8
DOIs	https://doi.org/10.1093/ndt/gfz047
State	Published - 1 Aug 2020

Bibliographical note

Publisher Copyright:
© 2020 Oxford University Press. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ndt/gfz047

Fingerprint

Dive into the research topics of 'Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)'. Together they form a unique fingerprint.

Cite this

Sarafidis, P., Ferro, C. J., Morales, E., Ortiz, A., Malyszko, J., Hojs, R., Khazim, K., Ekart, R., Valdivielso, J., Fouque, D., London, G. M., Massy, Z., Ruggenenti, P., Porrini, E., Wiecek, A., Zoccali, C., Mallamaci, F., & Hornum, M. (2020). Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407). Nephrology Dialysis Transplantation, 35(8), 1452. https://doi.org/10.1093/ndt/gfz047

Sarafidis, Pantelis ; Ferro, Charles J. ; Morales, Enrique et al. / Erratum : SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407). In: Nephrology Dialysis Transplantation. 2020 ; Vol. 35, No. 8. pp. 1452.

@article{6738a37c5e184370bbab31e49d091bd7,

title = "Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)",

abstract = "SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA, Nephrology Dialysis Transplantation, Volume 34, Issue 2, 1 February 2019, Pages 208–230, https://doi.org/10.1093/ndt/gfy407 In the above article the first name of author Andrzej Wiecek was misspelled. The error has been corrected online.",

author = "Pantelis Sarafidis and Ferro, {Charles J.} and Enrique Morales and Alberto Ortiz and Jolanta Malyszko and Radovan Hojs and Khaled Khazim and Robert Ekart and Jose Valdivielso and Denis Fouque and London, {G{\'e}rard M.} and Ziad Massy and Petro Ruggenenti and Esteban Porrini and Andrzej Wiecek and Carmine Zoccali and Francesca Mallamaci and Mads Hornum",

year = "2020",

month = aug,

day = "1",

doi = "10.1093/ndt/gfz047",

language = "אנגלית",

volume = "35",

pages = "1452",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "8",

}

Sarafidis, P, Ferro, CJ, Morales, E, Ortiz, A, Malyszko, J, Hojs, R, Khazim, K, Ekart, R, Valdivielso, J, Fouque, D, London, GM, Massy, Z, Ruggenenti, P, Porrini, E, Wiecek, A, Zoccali, C, Mallamaci, F & Hornum, M 2020, 'Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)', Nephrology Dialysis Transplantation, vol. 35, no. 8, pp. 1452. https://doi.org/10.1093/ndt/gfz047

Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407). / Sarafidis, Pantelis; Ferro, Charles J.; Morales, Enrique et al.
In: Nephrology Dialysis Transplantation, Vol. 35, No. 8, 01.08.2020, p. 1452.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)

AU - Sarafidis, Pantelis

AU - Ferro, Charles J.

AU - Morales, Enrique

AU - Ortiz, Alberto

AU - Malyszko, Jolanta

AU - Hojs, Radovan

AU - Khazim, Khaled

AU - Ekart, Robert

AU - Valdivielso, Jose

AU - Fouque, Denis

AU - London, Gérard M.

AU - Massy, Ziad

AU - Ruggenenti, Petro

AU - Porrini, Esteban

AU - Wiecek, Andrzej

AU - Zoccali, Carmine

AU - Mallamaci, Francesca

AU - Hornum, Mads

PY - 2020/8/1

Y1 - 2020/8/1

N2 - SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA, Nephrology Dialysis Transplantation, Volume 34, Issue 2, 1 February 2019, Pages 208–230, https://doi.org/10.1093/ndt/gfy407 In the above article the first name of author Andrzej Wiecek was misspelled. The error has been corrected online.

AB - SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA, Nephrology Dialysis Transplantation, Volume 34, Issue 2, 1 February 2019, Pages 208–230, https://doi.org/10.1093/ndt/gfy407 In the above article the first name of author Andrzej Wiecek was misspelled. The error has been corrected online.

UR - http://www.scopus.com/inward/record.url?scp=85090178690&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfz047

DO - 10.1093/ndt/gfz047

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 30820538

AN - SCOPUS:85090178690

SN - 0931-0509

VL - 35

SP - 1452

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

IS - 8

ER -

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R et al. Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407). Nephrology Dialysis Transplantation. 2020 Aug 1;35(8):1452. doi: 10.1093/ndt/gfz047